ASH 2014: Highlights in CLL from ASH 2014

ASH 2014: Highlights in multiple myeloma

Comment: New PD-1 checkpoint inhibitors for treating Hodgkin lymphoma

HIV-associated lymphoma responds well to stem cell transplantation

E-hospital: Fully coordinated cancer care and research in Europe

Molecular targeting in cancer and the impact on personalised medicine

Advances in multiple myeloma: Expert panel discussion

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Novel targeting in acute myeloid leukaemia

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia

Personalisation of leukaemia treatment using genome sequencing

History and ongoing work of AORTIC